Search Results

DiscoverX , a global leader in GPCR product solutions including cell-based assay product solutions supporting drug discovery, development, and regulatory submission. This partnership is designed to support the GPCR research community by expanding access to validated, Their cell-based assays support a wide range of mechanisms of action, including cAMP accumulation, β-arrestin These assays are widely accepted by industry and regulators and are supported by thousands of peer-reviewed

It is designed as a continuous learning environment — supporting scientific reasoning as programs mature The next live AMA will take place: Thursday, February 26th at 12:00 PM EST You are invited to submit antagonism or obscuring subtle allosteric behavior. Key diagnostic considerations: Curved Schild plots suggest occupancy-limited modulation Linear plots High-expression systems maximize detection sensitivity and can reveal subtle efficacies.

In reality, something more subtle starts to shift. 👉 Decision-making changes. They surface only after commitments have already been made. When building quietly turns into surviving 👉 At a certain point, many biotech founders  believe they are still building the company, while in reality, they have already shifted into survival mode. They mean something more subtle. The company is reacting instead of choosing.

events: 12th Adhesion GPCR Workshop; GPCRnet International Symposium; 5th GPCRs Targeted Drug Discovery Summit This soft launch prioritizes usability and clarity to support stronger GPCR drug discovery decisions Subscribe to the free Kenakin Brief Newsletter to join the AMA . Submit your work today ➤ Why Dr. It supports scientists refining expertise. It strengthens teams executing discovery programs.

. 👉 What actually happens is more subtle. Hiring decisions are pulled forward to support a story. In strong biotech startups, they surface as reasonable adjustments that seem aligned with reality. Roles are added to demonstrate scale, even when the organization is not structurally ready to support Under these conditions, decision making begins to shift subtly.

The Ames test, a foundational bacterial assay, surfaces as an early alert for DNA-modifying liabilities High-Dose Investigations Regulatory guidance requires toxic effects to be observed—if achievable—at sufficiently

🔍 This Week in Dr.GPCR Premium: Sneak Peek Upcoming events:  5th GPCRs Targeted Drug Discovery Summit Here's how: Watch the course trailer ➤ Read the blog post ➤ Subscribe to the Kenakin Brief ➤ Dr. Your membership also supports open educational resources for the global GPCR community, ensuring depth guidance on career paths, choosing research topics, switching fields, and learning from both failures and successes

Sustainable biotech growth depends on leaders reinforcing direction as decisions accumulate, not on perfect Founders who prevent silent failure do not wait for problems to surface. ✅ They continuously reinforce

Investor calls take too long before reaching substance. Clear biotech positioning creates the conditions where scientific depth supports confident decisions The most damaging effect is subtle. ✅ Founders start adapting their message in real time , trying to Improving slides or polishing the pitch may reduce surface-level friction, but the core problem remains Science supports the conversation instead of driving it off course. ✅ The result is not smoother selling

. 👉 It feels logical to evaluate success where it is most visible . quietly shapes everything that follows , not through dramatic moves or bold announcements, but through subtle 👉 Milestones, progress signals, and success criteria are often assumed rather than agreed upon. Before assumptions turn into dogma. ✅ Early strategic decision-making does not guarantee success, but They focus on creating a clear decision environment that supports consistent execution later on.

. ✅ This is where survival is decided. Early-stage biotech hiring is not about perfect resumes. They are never sufficient. that survival traits are not abstract qualities. Survival traits determine whether anything gets done when they are not. How Founders Can Hire for Survival Without Overengineering It 👉 Once founders recognize that survival

The difference between surviving and failing in biotech is rarely science. Teams are no longer sure what success looks like. 👉 No single decision breaks the company, but the absence Teams that regain control do not suddenly become more confident about biology. Founders who succeed understand that strategy is not a one-time exercise. Instead of letting chaos accumulate quietly, they surface it early.

Biotech fundraising has undergone a subtle yet significant shift. What investors are really assessing is how clearly intellectual property supports the business being Slides list filings and dates, but do not explain how those rights support the fundraising narrative It fails when intellectual property does not clearly support the business being built.   . 👉 Founders who raise successfully treat intellectual property as part of their core narrative.

. 👉 When your cadence is unstable: Timelines slip quietly Dependencies surface late Teams optimize for activity, not momentum Scientific surprises hit harder because the system has no buffer ✅ What “good ✅ A stable cadence doesn’t eliminate surprise. It eliminates blindness .

Premium Sneak Peak:  Human Substance P–NK1R interactions observed by NMR; Endocrine Metabolic GPCRs 2026 Design GPCR binding affinity experiments that tell the truth , ensuring affinity data support—rather A quick rating on Spotify or Apple Podcasts — and a YouTube subscribe — helps us reach more scientists Beyond access, Premium sustains the nonprofit mission behind Dr. GPCR—supporting open resources while giving members deeper insight and earlier visibility.

The danger is subtle: 👉Scientific isolation feels busy, intelligent, respectable. But strategically, it’s suffocating.

Tracers bind not only to receptors but also to surfaces and unwanted proteins; non-specific binding must Proteins are not inert surfaces, and orthosteric binding reactions often continue beyond the first encounter This frequently masquerades as: Two binding sites Multiple receptor subtypes Allosteric modulation But Small differences produce subtle curvature; large differences produce biphasic behavior. Non-specific binding control:  Adsorption to surfaces changes free ligand concentration.

mindset and tactics he’s used for years—including the exact line that makes intimidating conversations surprisingly

No loud red flags.Just a series of subtle but firm questions pointing to what’s missing . Clarity, not complexity, is what makes approval possible, and biotech sustainable. 5️⃣ Patient targeting rationale: Are you selecting the right patient subgroup with a clear justification Building FDA-Ready Thinking into Your Strategy Regulatory success is not a function. If you can’t see them too, you’re not building strategy, you’re building surprises.

Subcellular membrane mixtures, altered receptor conformations, and non-specific interactions introduce events under near-physiological conditions while simultaneously generating image-based evidence to support localization, membrane composition, and intracellular trafficking states influence ligand binding in subtle , fluorescent tracers such as CELT-331 can report on ligand competition events directly at the cell surface Notably, no compound displayed toxicity or morphological changes at this concentration, supporting the

They could be engineered to target surface-exposed receptors, remain stable across batches, support live-cell imaging, and tolerate super-resolution workflows. Designing Reliable GPCR Imaging Tools for Real Biological Systems Success brought new challenges. The payoff was substantial. These optimizations enabled dual-color labeling strategies, surface-selective imaging, and ultimately

probes—designed with precise synthetic logic—enable deeper insight into GPCR internalization, trafficking, and surface What You’ll Learn Why peptide–fluorophore probes succeed where antibodies fail How parallel synthesis & testing accelerates probe optimization How surface-exposed receptor pools reshape interpretations of Help us reach more scientists by providing quick rating on Spotify or Apple Podcasts — and a YouTube subscribe GPCR is a 501(c)(3) non-profit organization—your participation directly supports our mission to advance

And they avoid the costly surprises that appear when in vitro conclusions collide with human physiology These nonlinearities matter: Competitive inhibition decreases as substrate increases. Uncompetitive inhibition strengthens as substrate increases—opposite of intuition. A compound may appear benign with one substrate and problematic with another. Kenakin reveals  the substrate strategy needed for credible DDI assessment.

It’s survival. Suddenly, the anomalies aligned.

The resulting multiparametric datasets are well-suited for GPCR research, where receptor trafficking, For GPCR assay developers, HCS supports:  Quantitative visualization of receptor internalization and Assay Design and Pilot Optimization Successful HCS begins with a clearly defined biological question Probe panels—such as lysosomal dyes or cytoskeletal markers—can be integrated to support multiplexed At Celtarys, we remain committed to enabling this transition and supporting researchers as they design

Scientific progress doesn’t guarantee startup success; strategic clarity does. By the time it surfaces, you’ve lost two months of budget and alignment. 2️⃣ Milestone redefinition Most biotech founders don’t suffer from having the wrong people. They suffer because everyone has a different idea of what their role actually is.   And suddenly, it becomes obvious what to kill and what to scale. ✅ That’s the power of strategic realignment

Watch Episode #177 The Experiment That Was Never Meant to Succeed When David Hodson’s lab teamed up with visualization tool Impact:  Shared widely → now used globally to map GPCR activity in live systems The success peripheral contributions to metabolic therapy Guide how next-generation incretin drugs are designed Support

Surgery electives meant long nights, constant patient responsibilities, and unpredictable call schedules For Hodson, one sustained curiosity thread involved a protein released by alpha cells in the pancreas Suddenly, the puzzle snapped into place. A long-running side project became a central insight.

Others show subtle curvature or slope deviations. It ’s a screening tool, not a substitute for rigorous Schild validation. Common revelations include: Mixtures of receptor subtypes  producing hybrid response patterns.

Catch subtle mechanistic drift.   GPCR is a nonprofit organization , and Premium Membership directly supports our mission to make reliable University content, and an integrated view of publications, events, insights, and opportunities designed to support